Perinvest (Lux) SICAV - Global Healthcare Equity


The Perinvest (Lux) SICAV - Global Healthcare Equity fund focuses on publicly listed equity investments in innovative healthcare companies. The fund has a global mandate with a focus on Europe and the US. The manager uses a bottom-up stock selection process with the fund typically containing 25-50 companies in a diversified portfolio.


Nabil Gharios is the Portfolio Manager of the Global Healthcare Equity Sub-Fund at Perinvest (UK) Limited

Nabil started his career in 1999 at SG Cowen, as a financial analyst for the healthcare M&A division (New York). Between 2001 and 2005, Nabil was an associate at Bioam, a €51m venture-capital fund specialized in biotechnologies (Paris). He then worked for 5 years at Abbott Laboratories where he held several positions, including manager of the European business development team, international brand manager for anesthesia (600 M€ revenue) and special project manager for the European Headquarter. In late 2011, Nabil founded Biotech Promise, a specialized investment fund dedicated to listed biotech and medtech companies. He still serves as the portfolio manager of the fund.

Nabil graduated from Ecole Centrale de Paris, a leading French engineering university, and is currently responsible for the healthcare sector of the French Society of Financial Analysts (SFAF).

Perinvest (Lux) SICAV - Global Healthcare Equity April 2022 Factsheet

Perinvest (Lux) SICAV - Global Healthcare Equity KIID Class B